Keyphrases
Quality of Life
100%
Asthma Symptoms
100%
Zafirlukast
100%
Chronic Airflow Obstruction
100%
Placebo
44%
Twice Daily
22%
Asthma Symptom Score
22%
Long-term Treatment
11%
Multicenter Trial
11%
Asthma
11%
Pulmonary Function
11%
Patient Well-being
11%
Airway Disease
11%
Placebo-controlled
11%
Safety Profile
11%
Disease-specific
11%
Activity Limitations
11%
Change from Baseline
11%
Adverse Events
11%
Overall Quality of Life
11%
Consecutive Days
11%
Mild-to-moderate Asthma
11%
Environmental Stimuli
11%
Emotional Skills
11%
Forced Expiratory Volume in 1 Second (FEV1)
11%
Peak Expiratory Flow Rate
11%
Laboratory Results
11%
Leukotriene Receptor Antagonist
11%
Event Information
11%
Daytime Symptoms
11%
Clinical Laboratory Test
11%
Quality of Life Domains
11%
Clinically Meaningful Improvement
11%
Asthma Quality of Life Questionnaire
11%
Score Function
11%
Nocturnal Symptoms
11%
Nighttime Awakenings
11%
Nasal Congestion Score
11%
Medicine and Dentistry
Airway Obstruction
100%
Quality of Life
100%
Asthma
100%
Zafirlukast
100%
Placebo
55%
Adverse Event
11%
K-Complex
11%
Respiratory Disease
11%
Lung Function
11%
Laboratory Test
11%
Peak Expiratory Flow
11%
Leukotriene Receptor Blocking Agent
11%
Nasal Congestion
11%
Diseases
11%
Pharmacology, Toxicology and Pharmaceutical Science
Airway Obstruction
100%
Asthma
100%
Zafirlukast
100%
Placebo
55%
Adverse Event
11%
Respiratory Tract Disease
11%
Leukotriene Receptor Blocking Agent
11%
Nose Obstruction
11%
Diseases
11%
Neuroscience
Zafirlukast
100%
Quality of Life
100%
Placebo
55%
Agonist
33%
Peak Expiratory Flow
11%
Leukotriene Antagonist
11%